Palifermin, a recombinant human keratinocyte growth factor, triggers reactivation of anogenital human papillomavirus infection in a HIV-positive patient with diffuse large cell B-cell non-Hodgkin lymphoma.
Schroeder
T
T
Zohren
F
F
Saure
C
C
Kobbe
G
G
Haas
R
R
D052685:Alphapapillomavirus; D003218:Condylomata Acuminata / Q000139:chemically induced / Q000473:pathology / Q000628:therapy / Q000821:virology; D051523:Fibroblast Growth Factor 7 / Q000008:administration & dosage / Q000009:adverse effects*; D006679:HIV Seropositivity / Q000150:complications / Q000473:pathology / Q000628:therapy / Q000821:virology; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000473:pathology / Q000628:therapy / Q000821:virology; D008297:Male; D013280:Stomatitis / Q000517:prevention & control
D051523:Fibroblast Growth Factor 7